We developed and assessed the diagnostic value of a novel quantitative nested real-time (QNRT) PCR assay targeting the internal transcribed spacer region of ribosomal DNA (rDNA) in a guinea pig model of invasive pulmonary aspergillosis. Groups of 5 immunosuppressed animals that were infected using an aerosol chamber with Aspergillus fumigatus conidia were humanely terminated 1 h postinoculation and at days 3, 5, 7, and 11 postchallenge, and lung tissue, bronchoalveolar lavage (BAL) fluid, whole blood, and serum samples were collected. The QNRT PCR results obtained with the serum and BAL fluid were compared to those achieved with galactomannan and (1→3)-β-d-glucan assays. High fungal burden levels were detected by QNRT PCR in both lung tissue and BAL fluid in all infected animals at each time point, and the sensitivity of each assay in BAL fluid was 100% by day 3 and remained so through the remainder of the study. The sensitivity of detection of fungi in whole blood and serum samples was significantly lower, and some samples remained negative by all three assays despite the advanced stage of the infection. From these data, we can conclude that this novel QNRT PCR method was highly sensitive for the detection of A. fumigatus from different types of samples in this model. In addition, BAL fluid samples appeared to be the most suitable for the early diagnosis of invasive pulmonary aspergillosis. When testing serum, the use of a combination of available assays may increase the possibility of early detection of this opportunistic mycosis.

Department of Internal Medicine—Hematooncology Faculty of Medicine of Masaryk University and University Hospital Brno Brno Czech Republica

See more in PubMed

Becker MJ, et al. 2003. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br. J. Haematol. 121:448–457 PubMed

Christie JD. 2003. Diagnosis of invasive mold infection. Is PCR the answer? Am. J. Clin. Pathol. 119:38–44 PubMed

De Pauw B, et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813–1821 PubMed PMC

Espy MJ, et al. 2006. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin. Microbiol. Rev. 19:165–256 PubMed PMC

Ferns RB. 2006. Evaluation of the role of real-time PCR in the diagnosis of invasive aspergillosis. Leuk. Lymphoma 47:15–20 PubMed

Francesconi A, et al. 2006. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J. Clin. Microbiol. 44:2475–2480 PubMed PMC

Graybill JR, Kaster SR. 1984. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. Am. Rev. Respir. Dis. 129:292–295 PubMed

Khan ZU, Ahmad S, Theyyathel AM. 2008. Diagnostic value of DNA and (1→3)-d-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with Fusarium oxysporum. 47301-0. J. Med. Microbiol. 57:36–42 PubMed

Klingspor L, Loeffler J. 2009. Aspergillus PCR formidable challenges and progress. Med. Mycol. 47(Suppl. 1):S241–S247 PubMed

Maertens J, et al. 2009. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49:1688–1693 PubMed

Meersseman W, et al. 2008. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am. J. Respir. Crit. Care Med. 177:27–34 PubMed

Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9:89–96 PubMed

Mennink-Kersten MASH, Ruegebrink D, Wasei N, Melchers WJG, Verweij PE. 2006. In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-{beta}-d-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 44:1711–1718 PubMed PMC

Miceli MH, et al. 2008. Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin. Infect. Dis. 46:1412–1422 PubMed

Morton CO, et al. 2010. Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum. J. Med. Microbiol. 59:408–413 PubMed

National Academy of Sciences 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC

Neofytos D, et al. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin. Infect. Dis. 48:265–273 PubMed

Nierman WC, et al. 2005. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438:1151–1156 PubMed

Nogva HK, Rudi K. 2004. Potential influence of the first PCR cycles in real-time comparative gene quantifications. Biotechniques 37:246–248, 250–253 PubMed

Pagano L, Caira M, Valentini CG, Posteraro B, Fianchi L. 2010. Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Blood Rev. 24:51–61 PubMed

Patterson TF. 2005. The future of animal models of invasive aspergillosis. Med. Mycol. 43(Suppl. 1):S115–S119 PubMed

Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B. 2007. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J. Clin. Microbiol. 45:906–914 PubMed PMC

Sheppard DC, et al. 2006. Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin. Microbiol. Infect. 12:376–380 PubMed

Sheppard DC, et al. 2004. Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 48:1908–1911 PubMed PMC

Tuon FF. 2007. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev. Iberoam. Micol. 24:89–94 PubMed

Vallor AC, et al. 2008. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob. Agents Chemother. 52:2593–2598 PubMed PMC

Wessa P. 2011. Free statistics software, Office for Research Development and Education, version 1.1.23-r7. http://www.wessa.net/

Zhao Y, et al. 2010. Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification. J. Clin. Microbiol. 48:1378–1383 PubMed PMC

Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR